Wall Street analysts expect Israel Chemicals Shs (NYSE:ICL) to report $0.09 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Israel Chemicals Shs’ earnings. The highest EPS estimate is $0.09 and the lowest is $0.08. Israel Chemicals Shs also posted earnings per share of $0.09 in the same quarter last year. The business is expected to report its next quarterly earnings report on Wednesday, November 22nd.

On average, analysts expect that Israel Chemicals Shs will report full year earnings of $0.28 per share for the current financial year, with EPS estimates ranging from $0.27 to $0.28. For the next financial year, analysts forecast that the business will report earnings of $0.34 per share, with EPS estimates ranging from $0.33 to $0.35. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Israel Chemicals Shs.

Israel Chemicals Shs (NYSE:ICL) last announced its earnings results on Thursday, August 3rd. The basic materials company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by $0.01. The business had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.32 billion. Israel Chemicals Shs had a positive return on equity of 13.55% and a negative net margin of 3.43%. The business’s revenue was down 4.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.09 EPS.

Several research firms have recently weighed in on ICL. Zacks Investment Research upgraded shares of Israel Chemicals Shs from a “sell” rating to a “hold” rating in a research report on Monday, July 17th. ValuEngine upgraded shares of Israel Chemicals Shs from a “hold” rating to a “buy” rating in a research report on Saturday, June 17th. BidaskClub upgraded shares of Israel Chemicals Shs from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. Finally, Jefferies Group LLC began coverage on shares of Israel Chemicals Shs in a research report on Thursday, May 25th. They set a “hold” rating and a $4.75 price objective for the company. One research analyst has rated the stock with a sell rating and four have issued a hold rating to the stock. The company presently has an average rating of “Hold” and an average target price of $4.67.

Israel Chemicals Shs (ICL) opened at 4.41 on Tuesday. Israel Chemicals Shs has a 12 month low of $3.52 and a 12 month high of $4.95. The firm’s market cap is $5.62 billion. The firm’s 50-day moving average is $4.68 and its 200-day moving average is $4.43.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Tuesday, August 29th will be issued a $0.0245 dividend. This represents a $0.10 annualized dividend and a dividend yield of 2.22%. The ex-dividend date is Tuesday, August 29th. Israel Chemicals Shs’s payout ratio is -66.66%.

COPYRIGHT VIOLATION NOTICE: This report was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://theolympiareport.com/2017/08/22/zacks-analysts-anticipate-israel-chemicals-shs-icl-to-post-0-09-earnings-per-share.html.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Renaissance Technologies LLC boosted its position in shares of Israel Chemicals Shs by 4.8% in the fourth quarter. Renaissance Technologies LLC now owns 329,400 shares of the basic materials company’s stock valued at $1,354,000 after buying an additional 15,200 shares during the last quarter. Bank of Montreal Can boosted its position in shares of Israel Chemicals Shs by 83.0% in the first quarter. Bank of Montreal Can now owns 879,248 shares of the basic materials company’s stock valued at $3,745,000 after buying an additional 398,754 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Israel Chemicals Shs by 10.4% in the first quarter. Bank of New York Mellon Corp now owns 1,520,221 shares of the basic materials company’s stock valued at $6,476,000 after buying an additional 143,262 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Israel Chemicals Shs by 6.4% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 111,890 shares of the basic materials company’s stock valued at $475,000 after buying an additional 6,744 shares during the last quarter. Finally, Karp Capital Management Corp purchased a new position in shares of Israel Chemicals Shs during the first quarter valued at approximately $782,000. Institutional investors own 5.95% of the company’s stock.

Get a free copy of the Zacks research report on Israel Chemicals Shs (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Israel Chemicals Shs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals Shs and related companies with Analyst Ratings Network's FREE daily email newsletter.